Results 11 to 20 of about 129,683 (162)

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature [PDF]

Leukemia Research Reports
Introduction and Importance: Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (pH-positive ALL) in Jehovah’s Witness (JW) using chemotherapy agents, opens an ethically and morally challenging paradigm instead of their religious ...
Muhammad Hassan Raza, Eiraj Khan, Alexis M Desjarlais, Salman Fazal   +3 more
doaj   +2 more sources

Immune‐mediated thrombotic thrombocytopenic purpura in a Jehovah’s Witness – Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab [PDF]

Clinical Case Reports, 2022
We report the case of a Jehovah's Witness adolescent patient with immune‐mediated thrombotic thrombocytopenic purpura after SARS‐Cov2 infection successfully treated without therapeutic plasma exchange (TPE) using caplacizumab, corticosteroids, rituximab,
Teresa Marta Cardesa‐Salzmann, Bernhard Stephan, Arne Simon, Rhoikos Furtwängler, Dominik Schöndorf, Sabine Heine, Eyad Torfah, Margaux Lux, Sonja Meyer, Norbert Graf   +9 more
doaj   +2 more sources

Pulmonary Thromboendarterectomy in a Jehovah’s Witness Patient, Case Report [PDF]

Annals of Cardiac Anaesthesia
This study describes the perioperative management of a 68-year-old Jehovah’s Witness patient with chronic pulmonary thromboembolism, multiple comorbidities, and undergoing pulmonary thromboendarterectomy.
Luz J. Pacheco Leal, Fabio A. Garcia Salamanca, Julián M. Parada, Gianmarco Camelo Pardo, Edgar F. Manrique-Hernandez   +4 more
doaj   +2 more sources

First Lung Transplantation in Jehovah’s Witness Patient in Latin America [PDF]

Clinical Medicine Insights: Case Reports, 2020
Lung transplantation is a life-saving alternative for patients with end-stage lung disease. The procedure itself has a high risk of bleeding. Jehovah’s Witness patients refuse to accept blood products due to religious beliefs.
Liliana Fernandez-Trujillo, Fernando Sanabria, Diego F Bautista, Mauricio Velazquez, Indira Cujiño, Eric Tafur, Daniel Arboleda, Valeria Zuñiga-Restrepo, Willian Martinez   +8 more
doaj   +2 more sources

Management of Severe Anemia in a Jehovah’s Witness Patient With Lung Abscess Secondary to Malpositioned Laparoscopic Adjustable Gastric Band: A Case Report [PDF]

Journal of Investigative Medicine High Impact Case Reports
Jehovah’s Witnesses is a Christian denomination widely recognized for their steadfast refusal of blood transfusions, even when facing severe anemia. We describe a unique case of a 42-year-old Jehovah’s Witness woman with severe iron deficiency anemia ...
Nina Ruan BA, Chloe Shi, Zain Al-Momani MD, Fouad Jaber MD, Ramy Ghaly MD, David Wooldridge MD   +5 more
doaj   +2 more sources

Staged open surgery for bicuspid aortic valve regurgitation and coarctation of the aorta in a Jehovah’s witness [PDF]

BMC Cardiovascular Disorders, 2020
Background Jehovah’s Witnesses refuse allogeneic blood transfusions, which makes cardiovascular surgery challenging. Surgeons must minimize blood and fluid loss within one procedure.
Kohei Sumi, Shigehiko Yoshida, Yoshitaka Okamura, Tomokazu Nakamura   +3 more
doaj   +2 more sources

Should Jehovah’s Witness patients be listed for heart transplantation? [PDF]

The Egyptian Heart Journal, 2014
This best evidence topic in Cardiac Surgery was written according to a structured protocol. The question addressed was: for [Jehovah’s Witness patients with end-stage heart failure] can these patients undergo a [heart transplantation] without an ...
Elsayed Elmistekawy, Thierry G. Mesana, Marc Ruel   +2 more
doaj   +2 more sources

A Jehovah’s Witness with Acquired Hemophilia A Who Successfully Avoided Blood Transfusions by Receiving Emicizumab [PDF]

Transfusion Medicine and Hemotherapy
Introduction: Acquired hemophilia A (AHA) manifests as a significant deficiency in coagulation factor VIII (FVIII) activity caused by the development of autoantibodies against FVIII and results in severe bleeding symptoms that can be life ...
Makoto Saito, Atsushi Yasumoto, Masahiro Ieko, Naoki Miyashita, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Akio Mori, Masanobu Morioka, Takeshi Kondo   +9 more
doaj   +2 more sources

Cardiac surgery in Jehovah’s Witness children: Clinical characteristics and outcomes from a limited single-center cohort [PDF]

Annals of Pediatric Cardiology
Background: Jehovah’s Witnesses (JWs), a religious group with over 9 million members globally, refuse allogeneic blood transfusions on religious grounds.
Nikita Panigrahi, Harohalli Aswathanarayana Venkatesh, Manas Ranjan Mishra, Lalchand H Bandagi, Jyoti Thadlani, Ramesh Reddy, Nijagal Shivanna Devananda   +6 more
doaj   +2 more sources

A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions [PDF]

Case Reports in Hematology, 2014
Therapy for acute leukemia in Jehovah’s Witnesses patients is very challenging because of their refusal to accept blood transfusions, a fundamental supportive therapy for this disease.
Yumi Yamamoto, Akihito Kawashima, Eri Kashiwagi, Kiyoyuki Ogata   +3 more
doaj   +2 more sources